PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Alasdair Henderson

University of Glasgow

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

PET, Proteomics, and Immunophenotyping of Arterial Inflammation and Checkpoint Inhibition

JAMA Cardiology

Prospective cohort study with multimodal imaging and biomarker endpoints showing no detectable arterial inflammation with ICIs or VEGFIs, directly addressing an important but incompletely resolved mechanistic question; limited by modest sample size and surrogate endpoints rather than hard clinical outcomes.

PromisingAlasdair Henderson Alastair J. Gemmell Stephen Rankin

Reported

Sample size55

ICI group size20

VEGFI group size15

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support